AQUEOUS PHARMACEUTICAL FORMULATIONS

Provided are an aqueous pharmaceutical formulation comprising an antibody specific to the receptor of interleukin (IL) -6 (for example, Tocilizumab) and an effective amount of histidine for stabilizing the antibody. Said histidine is present in the aqueous pharmaceutical formulation at a concentrati...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LIU, Jiung-Liang, YANG, Jheng-Gang, CHANG, Wen-Cheng
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided are an aqueous pharmaceutical formulation comprising an antibody specific to the receptor of interleukin (IL) -6 (for example, Tocilizumab) and an effective amount of histidine for stabilizing the antibody. Said histidine is present in the aqueous pharmaceutical formulation at a concentration of 50 mM to 200 mM so as to achieve the stabilizing effect. L'invention concerne une formulation pharmaceutique aqueuse comprenant un anticorps spécifique au récepteur de l'interleukine (IL)-6 (par exemple, Tocilizumab) et une quantité efficace d'histidine pour stabiliser l'anticorps. Ladite histidine est présente dans la formulation pharmaceutique aqueuse à une concentration de 50 mM à 200 mM de manière à obtenir l'effet stabilisant.